Isatuximab plus pomalidomide/dexamethasone versus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA Phase III study design

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2BWHeFD
via IFTTT